I appreciate your detailed request, but I need to clarify an important limitation: the search results provided don’t contain sufficient information to write a comprehensive article about “what new oral acne drugs are trying to avoid.”
The search results primarily focus on:
– Zasocitinib, a TYK2 inhibitor being developed by Takeda for psoriasis (not acne), which showed safety profiles similar to previous trials with common adverse events like upper respiratory infections and nasopharyngitis[1]
– An expert consensus study on isotretinoin use in acne vulgaris[2]
– FDA decisions expected in Q1 2026[3]
– A review of medicinal plants for acne that found limited evidence for fenugreek extract[4]
– Other dermatology drugs in development for hidradenitis suppurativa, not acne[6]
None of these results directly address what new oral acne drugs are attempting to avoid as a central topic. To write an accurate, well-sourced article on this subject, I would need search results that specifically discuss:
– New oral acne medications currently in development
– Their safety profiles and what adverse effects they’re designed to minimize
– How they differ from existing treatments like isotretinoin or other oral medications
– Clinical trial data showing what side effects or complications they’re targeting
I cannot write this article based on the current search results without fabricating information or making unsupported claims. Would you like me to help with a different query that the available sources can properly address, or would you prefer to provide additional search results focused specifically on new oral acne drug development?
